GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (FRA:BV3) » Definitions » Cyclically Adjusted Price-to-FCF

Bavarian Nordic AS (FRA:BV3) Cyclically Adjusted Price-to-FCF : (As of Jun. 04, 2025)


View and export this data going back to . Start your Free Trial

What is Bavarian Nordic AS Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Chart

Bavarian Nordic AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bavarian Nordic AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF falls into.


;
;

Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bavarian Nordic AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Bavarian Nordic AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-1.249/120.2000*120.2000
=-1.249

Current CPI (Mar. 2025) = 120.2000.

Bavarian Nordic AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -1.158 100.300 -1.388
201509 -0.173 100.200 -0.208
201512 -0.630 99.800 -0.759
201603 -0.328 100.200 -0.393
201606 -0.387 100.600 -0.462
201609 -0.854 100.200 -1.024
201612 2.052 100.300 2.459
201703 0.559 101.200 0.664
201706 0.999 101.200 1.187
201709 -0.292 101.800 -0.345
201712 -0.742 101.300 -0.880
201803 -0.783 101.700 -0.925
201806 -0.521 102.300 -0.612
201809 -0.097 102.400 -0.114
201812 -0.251 102.100 -0.295
201903 -0.599 102.900 -0.700
201906 -1.170 102.900 -1.367
201909 -0.611 102.900 -0.714
201912 -7.793 102.900 -9.103
202003 1.234 103.300 1.436
202006 0.470 103.200 0.547
202009 0.540 103.500 0.627
202012 -2.073 103.400 -2.410
202103 -0.486 104.300 -0.560
202106 -0.806 105.000 -0.923
202109 -0.107 105.800 -0.122
202112 -1.609 106.600 -1.814
202203 -0.537 109.900 -0.587
202206 -0.463 113.600 -0.490
202209 -0.118 116.400 -0.122
202212 -1.106 115.900 -1.147
202303 -0.833 117.300 -0.854
202306 0.222 116.400 0.229
202309 0.230 117.400 0.235
202312 0.592 116.700 0.610
202403 0.753 118.400 0.764
202406 -0.035 118.500 -0.036
202409 -0.806 118.900 -0.815
202412 0.546 118.900 0.552
202503 -1.249 120.200 -1.249

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bavarian Nordic AS  (FRA:BV3) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bavarian Nordic AS Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic AS Business Description

Industry
Address
Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines